✦ LIBER ✦

454 A phase II study of vinorebline (VRL) alterning oral and intravenous (IV) plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC)

✍ Scribed by M. Verrill; D. Serin; A. Jones; T. Delozier; R. Coleman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Navelbine® (NVB) alternating oral and i.

✍ D Serin; M Verrill; A Jones; T Delozier; R Coleman; B Longerey; S Lafaye de Mich 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 354 KB

A MULTICENTRIC PHASE II RANDOMISED STUDY

✍ T. Demkow; J. Kliment; A. Caty; F. Lesaunier; R. Abratt; F. Kasiborski; M. Brand 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Phase II study of vinorelbine (alternati

✍ Mario Campone; Maria Blasinska-Morawiec; Anna Tekiela; Piotr Koralewski; Jean-Ch 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 297 KB

456 PUBLICATION Phase II study of vinore

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

453 Phase I study of vinorelbine (VRL) a

✍ M. Campone; P. Fumoleau; A. Tekiela; P. Koralewski; J. Bonneterre; G. Blanchot; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

2114 POSTER Phase II study of an all-ora

✍ F. Nolé; C. Catania; G. Sanna; R. Mattioli; D. Crivellari; P. Foa; G. Pinotti; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB